More Fields

Filters

Profiles which have:

Recent Changes

Profiles with recent changes to:
Sign up to Download

1-6 of 6 results

  • www.epigenetix.com
  • 1
  • 1
  • 5
Studies with the dual BRD4 and p300/CBP inhibitor EP31670 (NEO2734) are now underway in Myelofibrosis in combination with a JAK inhibitor. We are also studying patients with other myeloid malignancies. Guided by our experience in solid tumor patients..
Relevance: 22.689396
  • jupiterneurosciences.com
  • 1
  • 21
Our mission is making a significant impact for patients and society through a safe and oral medication for Alzheimer's disease and for people with rare diseases... Jupiter Neurosciences, Inc. has developed the first and only resveratrol product that..
Relevance: 11.070408
  • www.camp4tx.com
  • 3
  • 27
At CAMP4, we are pioneering a novel approach to programmable ASO therapeutics. Our RAP platform's proprietary insights enable us to rapidly discover and develop ASO therapeutics to increase the expression of genes to address hundreds of diseases by..
Relevance: 10.231146
  • med.miami.edu
  • 24
  • 19
  • 101
The HIHG is committed to excellence in all aspects of genetics and genomics research. The HIHG faculty are leaders in applying genomic technology and genetic analysis methods to common complex disorders that have the largest impact on public health,..
Relevance: 2.9294643
  • med.miami.edu
  • 152
  • 9
  • 252
The Schiff Center of Liver Diseases is operated by a passionate group of people dedicated to our research goals and compassionate patient care... Education - We have 38 faculty members, 25 residents as well as 20 fellows, post doctorates, and other..
Relevance: 1.2871877
  • med.miami.edu
  • 155
  • 26
  • 253
We are one of the top 10 programs in the United States for children with neurodevelopmental disabilities and chronic illness. The Mailman Center is housed in a nine-story building with nearly 115,000 square feet of office, clinical, training,..
Relevance: 1.2871877